Skip to main content

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS) The program is funded by the Else Kröner-Fresenius Foundation (EKFS), one of the leading foundations supporting young investigators in medical science.

Structured Training at the Interface of Immunology, Neuroscience, and Genetics

IMMUNE PILOT combines the scientific excellence of the University of Bonn with the translational strength of UKB. Participants benefit from outstanding research infrastructure, including the Bonn Technology Campus, the DFG Cluster of Excellence ImmunoSensation³, and the German Center for Neurodegenerative Diseases (DZNE). In this environment, internationally leading researchers investigate key immunological and neurobiological mechanisms across the entire lifespan - with direct relevance to clinically important questions ranging from pediatrics and adolescent medicine to adult care.

The doctoral program is led by Prof. Kaan Boztug, Director of the Department of Pediatric Immunology and Rheumatology at UKB, and Prof. Anne-Katrin Pröbstel, Managing Director of the Department of Neurology and Director of the Department of Neuroimmunology and Neuromuscular Disorders at UKB as well as research group leader at DZNE. PD Dr. Michael Sommerauer, senior physician at the UKB Department of Neurology, serves as deputy. The program is supported by an interdisciplinary team of clinician scientists and natural scientists at the Bonn site, including several ERC-funded researchers.

“With IMMUNE PILOT, the University of Bonn and UKB are jointly strengthening the next generation of clinician scientists and the Bonn research hub - with a clear focus on translation and future readiness,” comments Prof. Uwe Reuter, Chairman of the Board and Medical Director at UKB, on the launch of the initiative.

The Dean of the Faculty of Medicine, Prof. Bernd Weber, also sees the new doctoral program as an important building block for the further development of the faculty: “We are delighted that the outstanding clinical leaders and professors Boztug and Pröbstel, who were newly recruited only last year, have succeeded with the concept of this innovative doctoral program. It is an important source of motivation and strong support for early-career clinical researchers, who can prepare not only for clinical practice but also for the innovative research that will shape the medicine of tomorrow.”

Strong Mentoring, International Exchange, and Translational Focus

At the core of IMMUNE PILOT are experimental doctoral projects featuring a twelve-month full-time research phase, followed by continuation alongside the students’ medical studies. The program offers close individual supervision, a structured qualification framework, and a flexible curriculum with methodological training, seminars, and key scientific skills. Mentoring, international exchange opportunities with existing partner institutions of the Faculty of Medicine at the University of Bonn - the Immunology Frontier Research Center (IFReC) at Osaka University and the Bonn-Cumming Program for Host-directed Therapies at the University of Melbourne - and early integration into the research community are integral components.

“With IMMUNE PILOT, we are closing the gap between traditional medical education and innovative translational research,” says Prof. Anne-Katrin Pröbstel. “This gives future physicians early access to cutting-edge technologies and prepares them for a scientific career that closely links clinical practice and research,” emphasizes Prof. Kaan Boztug.

 

Contact

Prof. Kaan Boztug
Director Clinic for Pediatric Immunology and Rheumatology at UKB
ImmunoSensation3 at the university of Bonn
Phone: (reception) +49(0)228-287 37852
E-Mail: kaan.boztug@ukbonn.de

Prof. Anne-Katrin Pröbstel
Director Center for Neurology & Clinic for Neuroimmunology at UKB
ImmunoSensation3 at the University of Bonn & DZNE
Phone: (reception) +49 (0) 228 287-31431
Email: anne-katrin.proebstel@ukbonn.de

Related news

News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Award Ceremony, SxDiagnostics

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.
View entry
Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry

Back to the news overview